Literature DB >> 11809799

The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development.

Richard Chan1, William R Hardy, Michael A Laing, Sarah E Hardy, William J Muller.   

Abstract

Activation of the epidermal growth factor receptor (EGFR) family is thought to play a critical role in both embryogenesis and oncogenesis. The diverse biological activities of the EGFR family are achieved through various ligand-receptor and receptor-receptor interactions. One receptor that has been found to play a central role in this signaling network is ErbB-2/Neu, and it is considered the preferred heterodimerization partner for other members of the EGFR family. To assess the importance of the catalytic activity of ErbB-2 in embryonic development, we have generated mice expressing a kinase-dead erbB-2 cDNA under the transcriptional control of the endogenous promoter. Here, we show that mice homozygous for the kinase-dead erbB-2 allele die at midgestation and display the same spectrum of embryonic defects seen in erbB-2 knockout mutants. These observations suggest that the catalytic activity of ErbB-2 is essential for normal embryonic development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809799      PMCID: PMC134647          DOI: 10.1128/MCB.22.4.1073-1078.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice.

Authors:  W Lin; H B Sanchez; T Deerinck; J K Morris; M Ellisman; K F Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.

Authors:  D B Weiner; Y Kokai; T Wada; J A Cohen; W V Williams; M I Greene
Journal:  Oncogene       Date:  1989-10       Impact factor: 9.867

Review 3.  Growth factor receptor tyrosine kinases.

Authors:  Y Yarden; A Ullrich
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development.

Authors:  J K Morris; W Lin; C Hauser; Y Marchuk; D Getman; K F Lee
Journal:  Neuron       Date:  1999-06       Impact factor: 17.173

5.  Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts.

Authors:  D G Wilkinson; M A Nieto
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

6.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

Authors:  S Hiratsuka; O Minowa; J Kuno; T Noda; M Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.

Authors:  X Qian; C M LeVea; J K Freeman; W C Dougall; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

8.  The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.

Authors:  N C Luetteke; H K Phillips; T H Qiu; N G Copeland; H S Earp; N A Jenkins; D C Lee
Journal:  Genes Dev       Date:  1994-02-15       Impact factor: 11.361

9.  ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.

Authors:  R Pinkas-Kramarski; M Shelly; B C Guarino; L M Wang; L Lyass; I Alroy; M Alimandi; A Kuo; J D Moyer; S Lavi; M Eisenstein; B J Ratzkin; R Seger; S S Bacus; J H Pierce; G C Andrews; Y Yarden; M Alamandi
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

10.  Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.

Authors:  X Qian; W C Dougall; M E Hellman; M I Greene
Journal:  Oncogene       Date:  1994-05       Impact factor: 9.867

View more
  23 in total

1.  Neuregulin in heart failure : reverse translation from cancer cardiotoxicity to new heart failure therapy.

Authors:  C A Geisberg; D J Lenihan
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

Review 2.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling.

Authors:  Joyce A Schroeder; Leslie F Jackson; David C Lee; Todd D Camenisch
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

3.  The emerging contaminant 3,3'-dichlorobiphenyl (PCB-11) impedes Ahr activation and Cyp1a activity to modify embryotoxicity of Ahr ligands in the zebrafish embryo model (Danio rerio).

Authors:  Monika A Roy; Karilyn E Sant; Olivia L Venezia; Alix B Shipman; Stephen D McCormick; Panithi Saktrakulkla; Keri C Hornbuckle; Alicia R Timme-Laragy
Journal:  Environ Pollut       Date:  2019-08-06       Impact factor: 8.071

Review 4.  The role of Neuregulin-1beta/ErbB signaling in the heart.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Exp Cell Res       Date:  2008-09-03       Impact factor: 3.905

Review 5.  Receptor tyrosine kinase signaling: regulating neural crest development one phosphate at a time.

Authors:  Katherine A Fantauzzo; Philippe Soriano
Journal:  Curr Top Dev Biol       Date:  2015-01-20       Impact factor: 4.897

6.  Expression and significance of HER family receptors in neuroblastic tumors.

Authors:  Ewa Izycka-Swieszewska; Agnieszka Wozniak; Elzbieta Drozynska; Jacek Kot; Wieslawa Grajkowska; Teresa Klepacka; Danuta Perek; Sylwia Koltan; Ewa Bien; Janusz Limon
Journal:  Clin Exp Metastasis       Date:  2011-01-04       Impact factor: 5.150

7.  Erbin is a negative modulator of cardiac hypertrophy.

Authors:  Inbal Rachmin; Sagi Tshori; Yoav Smith; Amit Oppenheim; Sylvie Marchetto; Gillian Kay; Roger S-Y Foo; Noa Dagan; Eliahu Golomb; Dan Gilon; Jean-Paul Borg; Ehud Razin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

Review 8.  The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.

Authors:  Jaclyn A Freudenberg; Qiang Wang; Makoto Katsumata; Jeffrey Drebin; Izumi Nagatomo; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2009-05-18       Impact factor: 3.362

9.  Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis.

Authors:  Eran R Andrechek; William R Hardy; Michael A Laing; William J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

10.  Enzymatic activity is required for the in vivo functions of CARM1.

Authors:  Daehoon Kim; Jaeho Lee; Donghang Cheng; Jia Li; Carla Carter; Ellen Richie; Mark T Bedford
Journal:  J Biol Chem       Date:  2009-11-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.